Literature DB >> 21907419

Role of glial cells in innate immunity and their role in CNS demyelination.

Subramaniam Sriram1.   

Abstract

The adaptive and innate arms of the immune system are the two pillars of host defense against environmental pathogens. Multiple sclerosis (MS) is an inflammatory demyelinating disease of the CNS which is considered to be autoimmune and is thought to result from breakdown in the usual checks and balances of the adaptive immune response. The major pathological outcome of the disease is "the MS plaque" a unique feature of CNS demyelination characterized by the destruction of oligodendrocytes with loss of myelin and underlying axons. The MS plaque is not seen in other inflammatory disorders of the CNS. The prevailing opinion suggests that MS is mediated by the activation of an adaptive immune response which targets neural antigens. Currently, the role of an innate immune in the development of the lesions in MS has remained unclear. We explore the potential cellular elements of the innate immune system and in particular glial cells, which are likely candidates in inducing the specific pathological picture that is evident in MS. Activated microglia and the release of molecules which are detrimental to oligodendrocyte have been suggested as mechanisms by which innate immunity causes demyelination in MS. However a microglia/macrophage centric model does not explain the specificity of lesion development in MS. We propose that activation pathways of receptors of the innate immune system present on oligodendrocytes and astrocytes rather than microglia are central to the pathogenesis of demyelination seen in MS. Copyright Â
© 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21907419     DOI: 10.1016/j.jneuroim.2011.08.012

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  20 in total

1.  CX3CL1/CX3CR1 Axis Plays a Key Role in Ischemia-Induced Oligodendrocyte Injury via p38MAPK Signaling Pathway.

Authors:  Xiao-Mei Wu; Yong Liu; Zhong-Ming Qian; Qian-Qian Luo; Ya Ke
Journal:  Mol Neurobiol       Date:  2015-07-20       Impact factor: 5.590

Review 2.  Receptor Tyrosine Kinase and Tyrosine Kinase Inhibitors: New Hope for Success in Multiple Sclerosis Therapy.

Authors:  Abbas Mirshafiey; Ghasem Ghalamfarsa; Babak Asghari; Gholamreza Azizi
Journal:  Innov Clin Neurosci       Date:  2014-07

3.  Activation of the STING adaptor attenuates experimental autoimmune encephalitis.

Authors:  Henrique Lemos; Lei Huang; Phillip R Chandler; Eslam Mohamed; Guilherme R Souza; Lingqian Li; Gabriela Pacholczyk; Glen N Barber; Yoshihiro Hayakawa; David H Munn; Andrew L Mellor
Journal:  J Immunol       Date:  2014-05-05       Impact factor: 5.422

4.  Gestational Hypothyroxinemia Imprints a Switch in the Capacity of Astrocytes and Microglial Cells of the Offspring to React in Inflammation.

Authors:  María C Opazo; Pablo A González; Betsi D Flores; Luis F Venegas; Eduardo A Albornoz; Pablo Cisternas; Karen Bohmwald; Pamela A Nieto; Susan M Bueno; Alexis M Kalergis; Claudia A Riedel
Journal:  Mol Neurobiol       Date:  2017-06-27       Impact factor: 5.590

5.  Characterization of the inflammatory response to solid cancer metastases in the human brain.

Authors:  Anna Sophie Berghoff; Hans Lassmann; Matthias Preusser; Romana Höftberger
Journal:  Clin Exp Metastasis       Date:  2012-07-01       Impact factor: 5.150

Review 6.  The significance of matrix metalloproteinases in the immunopathogenesis and treatment of multiple sclerosis.

Authors:  Abbas Mirshafiey; Babak Asghari; Ghasem Ghalamfarsa; Farhad Jadidi-Niaragh; Gholamreza Azizi
Journal:  Sultan Qaboos Univ Med J       Date:  2014-01-27

7.  Adenosine A2A receptor deficiency up-regulates cystatin F expression in white matter lesions induced by chronic cerebral hypoperfusion.

Authors:  Wei Duan; Hong Ran; Zhujuan Zhou; Qifen He; Jian Zheng
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

Review 8.  The benefits and detriments of macrophages/microglia in models of multiple sclerosis.

Authors:  Khalil S Rawji; V Wee Yong
Journal:  Clin Dev Immunol       Date:  2013-06-12

9.  Repurposing of Secukinumab as Neuroprotective in Cuprizone-Induced Multiple Sclerosis Experimental Model via Inhibition of Oxidative, Inflammatory, and Neurodegenerative Signaling.

Authors:  Amany El-Shahawy Abdel-Maged; Amany M Gad; Laila Ahmed Rashed; Samar S Azab; Eman A Mohamed; Azza S Awad
Journal:  Mol Neurobiol       Date:  2020-06-08       Impact factor: 5.682

10.  Induction of cytopathogenicity in human glioblastoma cells by chikungunya virus.

Authors:  Rachy Abraham; Prashant Mudaliar; Aiswaria Padmanabhan; Easwaran Sreekumar
Journal:  PLoS One       Date:  2013-09-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.